Characterization of ligno-cellulosic materials bleached with oxo-diperoxo-molybdates

A newly effective system was used to bleach ligno-cellulosic textile materials. This system is based on two different newly synthesized natrium oxo-diperoxo molybdates, Na₂[MoO (O₂)₂(C₂O₄)] and Na₂[MoO (O₂)₂(C₆H₆O₇)].     

Cross-linked amylose as matrix for drug controlled release. X-ray and FT-IR structural analysis

For cross-linked amylose (CLA) tablets prepared by direct compression, a linear increase in cross-linking degree (cld) defined as percentage of epichlorohydrin cross-linker/polymer, generates non-monotonous variation of drug release time. Controlled release (up to 20–24 h) properties were obtained only for tablets from CLA (Contramid^TM) with relatively low cld (CLA-2 up to CLA-6). Moderate increase in cld (CLA-15) generates a sharp decrease in the release time (2–6 h). This is a particular characteristic of the CLA matrix. The controlled release properties were related to the X-ray pattern of the dry CLA network. The increase in cld induces a transition from B-type (double helix) to a predominat V-type (single helix) and to more amorphous conformation of CLA powders. Furthermore, FT-IR data indicated low free water content at low cld. For low cross-linked CLA, chains are closely located and stabilized by HO groups involved in hydrogen bonding and thus more resistant to hydration and more appropriate for the control of drug release.     

Early Prediction of Sepsis Incidence in Critically Ill Patients Using Specific Genetic Polymorphisms

Several diagnostic methods for the evaluation and monitoring were used to find out the pro-inflammatory status, as well as incidence of sepsis in critically ill patients. One such recent method is based on investigating the genetic polymorphisms and determining the molecular and genetic links between them, as well as other sepsis-associated pathophysiologies. Identification of genetic polymorphisms in critical patients with sepsis can become a revolutionary method for evaluating and monitoring these patients. Similarly, the complications, as well as the high costs associated with the management of patients with sepsis, can be significantly reduced by early initiation of intensive care.     

The Use of Exosomes as Biomarkers for Evaluating and Monitoring Critically Ill Polytrauma Patients with Sepsis

Regarding genetic biomarkers for early assessment and monitoring the clinical course in polytrauma patients with sepsis, in recent years a remarkable evolution has been highlighted. One of the main representatives is the exosome miRNAs. In this paper, we would like to present in more details the various methods of using exosome miRNAs as a biomarker for monitoring polytrauma patients with sepsis, as well as establishing a belated outcome by aggregating the entire clinical aspects. The use of exosome miRNAs for late evaluating and monitoring the clinical evolution of polytrauma patients can bring significant improvements in current clinical practice through the optimization and modulation of intensive care according to the needs of each patient individually.